N-phenylalkyl-substituted tropane analogs of boat conformation with high selectivity for the dopamine versus serotonin transporter

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 23, 1999, Pages 3325-3328

  Prakash, K R C ^a   Tamiz, Amir P ^a   Araldi, Gian Luca ^a   Zhang, Mei ^b   Johnson, Kenneth M ^b   Kozikowski, Alan P ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; MAZINDOL; SEROTONIN; SEROTONIN TRANSPORTER; TROPANE DERIVATIVE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONFORMATION; DOPAMINE UPTAKE; NONHUMAN; SEROTONIN UPTAKE; SYNAPTOSOME; SYNTHESIS;

EID: 0033530810     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00607-1     Document Type: Article

References (26)

1. Johnson, C. E.; Fischman, M. W. Pharmacol. Rev. 1989, 41, 3-52.
2. Clouet, D.; Asghar, K.; Brown, R. (Eds.) NIDA Res. Monogr. 1988, 88.
3. Ritz, M. C.; Cone, E. J.; Kuhar, M. J. Life Sci. 1990, 46, 635-645.
4. Giros, B.; Jaber, M.; Jones, S. R.; Wightman, R. M.; Caron, M. G. Nature 1996, 379, 606-612.
5. Carroll, F. I.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. J. Med. Chem. 1992, 35, 969-981.
6. Chaudieu, I.; Vignon, J.; Chicheportiche, M.; Kamenka, J.-M.; Trouiller, G.; Chicheportiche, R. Pharmacol. Biochem. Behav. 1989, 32, 699-705.
7. Van der Zee, P.; Koger, H. S.; Gootjes, J.; Hespe, W. Eur. J. Med. Chem. 1980, 15, 363-370.
8. Clarke, R. L.; Daum, S. J.; Gambino, A. J.; Aceto, M. D.; Pearl, J.; Levitt, M.; Cumiskey, W. R.; Bogado, E. F. J. Med. Chem. 1973, 16, 1260-1267.
9. Meltzer, P. C.; Liang, A. Y.; Madras, B. K. J. Med. Chem. 1994, 37, 2001-2010.
10. Kotian, P.; Mascarella, S. W.; Abraham, P.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J.; Carroll, F. I. J. Med. Chem. 1996, 39, 2753-2763.
11. Smith, M. P.; Johnson, K. M.; Zhang, M.; Flippen-Anderson, J. L.; Kozikowski, A. P. J. Am. Chem. Soc. 1998, 120, 9072-9073.
12. Smith, M. P.; Hoepping, A.; Johnson, K. M.; Trzcinska, M.; Kozikowski, A. P. Drug Discovery Today 1999, 4, 322-332.
13. Anderson, P. H. J. Neurochem. 1987, 48, 1887-1896.
14. Dutta, A. K.; Coffey, L. L.; Reith, M. E. A. J. Med. Chem. 1998, 41, 699-705.
15. Anderson, P. H. Eur. J. Med. Chem. 1989, 166, 493-504.
16. Rothman, R. B.; Glowa, J. R. Mol. Neurobiol. 1995, 11, 1-19.
17. Villemagne V. L.; Rothman, R. B.; Yokoi, F.; Matecka, D.; Dannals, R. F.; Wong, D. F. Synapse 1999, 32, 44-50.
18. Sogaard, U.; Michalow, J.; Butler, B.; Lund Laursen, A.; Ingersen, S. H.; Skrumsager, B. K.; Rafaelsen, O. J. A. Int. Clin. Psychopharmacol. 1990, 5, 237-251.
19. Kozikowski, A. P.; Araldi, G. L.; Prakash, K. R. C.; Zhang, M.; Johnson, K. M. J. Med. Chem. 1998, 41, 4973-4982.
20. (a) Yi, S.-J.; Johnson, K. M. Eur. J. Pharm. 1991, 199, 185-189.
21. (b) Yi, S.-J.; Johnson, K. M. Neuropharmacol. 1991, 29, 475-486.
22. (c) Slusher, B. S.; Tiffany, C. W.; Olkowski, J. L.; Jackson, P. F. Drug Alcohol Depend. 1997, 48, 43-50.
23. 1H NMR spectra for all intermediates and final compounds were consistent with the assigned structures. All final compounds gave satisfactory C, H, N analyses. In case of compounds 4g and 4h, the purity was evaluated using separation methods of sequential gas chromatography/mass spectrometry measured in the EI mode at an ionization potential of 70 eV.
24. (a) Javitch, J. A.; Blaustein, R. O.; Snyder, S. H. Mol. Pharmacol. 1984, 26, 35-44.
25. (b) McElvain, J. S.; Schenk, J. O. Biochem. Pharmacol. 1992, 43, 2189-2199.
26. It is interesting to note that some N-arylalkyl "chair" tropanes have been reported, and that in this case the highest affinity ligand, methyl N-(3-phenylpropyl)-3β-(4-fluorophenyl)tropane-2β-carboxylate possessed a propylene linker. Meltzer, P. C.; Blundell, P.; Madras, B. K. Med. Chem. Res. 1998, 8, 12-34.